Yahoo! Sports

Forxiga™ (dapagliflozin), First-In-Class SGLT2 That Works Independently of Insulin, Now Approved in

PRINCETON, N.J. and LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYS: BMY) and AstraZeneca (NYS: AZN) today announced that the European Commission has approved Forxiga ™ (dapagliflozin) ...
FiercePharma

Forxiga™ (dapagliflozin), First-In-Class SGLT2 That Works Independently of Insulin, Now Approved in European Union for Treatment of Type 2 Diabetes

Forxiga™ (dapagliflozin), First-In-Class SGLT2 That Works Independently of Insulin, Now Approved in European Union for Treatment of Type 2 Diabetes Forxiga, a once-daily oral agent, provides ...
London South East

FORXIGA first in class SGLT2 gets EU approval

FORXIGA™ (DAPAGLIFLOZIN), FIRST-IN-CLASS SGLT2 THAT WORKS INDEPENDENTLY OF INSULIN, NOW APPROVED IN EUROPEAN UNION FOR TREATMENT OF TYPE 2 DIABETES FORXIGA tablets are indicated as a once-daily oral ...
India Infoline

AstraZeneca Pharma gets CDSCO nod for Dapagliflozin tablets

The company said it has received an Import and Market permission in Form CT-20 (Subsequent New Drug Approval) from the Central Drugs Standard Control Organisation, Directorate General of Health ...
Yahoo Style UK

Forxiga™ (dapagliflozin), First-In-Class SGLT2 That Works Independently of Insulin, Now Approved in

Add Yahoo as a preferred source to see more of our stories on Google. Forxiga tablets are indicated as a once-daily oral medication to improve glycaemic control in adult patients with type 2 diabetes.
Business Wire

Forxiga™ (dapagliflozin), First-In-Class SGLT2 That Works Independently of Insulin, Now Approved in European Union for Treatment of Type 2 Diabetes

Forxiga, a once-daily oral agent, provides physicians with a new option to improve glycaemic control as monotherapy in metformin-intolerant patients or combination therapy Reduction of weight and ...